|
|
Please log in to edit this profile
|
| Elevator Pitch |
CureDM Inc., which aims to stop or reverse diabetes by regenerating insulin-producing cells in the pancreas, said it will enter clinical trials after receiving $1 million of a possible $2.5 million Series C round. |
| Industry Focus |
Unspecified |
| Category |
Companies - Expansion Stage |
| Location |
100 Lancaster Avenue |
|
Suite R215 |
|
Wynnewood, Pennsylvania
19096
|
|
United States |
| |
| Phone |
610.645.6796 |
| Fax |
610.645.3055 |
| Email |
Please log in |
| Web |
http://www.curedm.com |
|
|
|
Amount: $1,000,000
Closed: August 17, 2009
|
|
|
|
| Be the first to recommend CureDM!
Log in |
Public information, member edits, and the DealHorizon.com team.
|
Office Location
Statistics
Search Site
Edit/Update
Followers
Please log in
Note: Once associated with a listing, Executives are automatically included as followers of that listing. Listing
creators are also automatically added as followers.
|
